Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Rheumatology

Getting an Accurate Diagnosis and Essential Testing

At a Glance

Relapsing polychondritis has no single confirmatory test. Doctors combine symptoms, medical history, clinical criteria, and targeted airway and heart tests, while using biopsy, PET/CT, or bronchoscopy selectively because each has limitations or risks.

Diagnosing relapsing polychondritis (RP) is often a process of “connecting the dots” rather than finding a single “smoking gun.” Because there is no single blood test that can definitively prove you have RP, doctors must synthesize your physical symptoms, medical history, and a suite of specialized tests to confirm the diagnosis and rule out mimics [1][2].

The Role of Clinical Criteria

To help guide this process, doctors often use established sets of rules called clinical criteria, such as the McAdam, Damiani-Levine, or Michet criteria [3]. These classification frameworks look for combinations of signs, like inflammation in both ears, joint pain, or eye redness.

However, these rules are aids for classification and research, not definitive diagnostic laws. Research has shown that they can miss evolving or limited disease. In one study of 87 patients clinically diagnosed with RP, 65.5% did not meet the traditional criteria because their symptoms were “limited” or atypical at the time [4]. If you don’t meet every checkmark on the list yet, it does not necessarily mean you don’t have the condition; a specialist may rely on follow-up and clinical judgment rather than a single checklist [1][5].

Evaluating Your Airway and Heart

Because RP can affect vital internal organs without initially causing obvious symptoms, your specialist will consider whether you need baseline screening of your respiratory and cardiovascular systems. The choice among tests is individualized, depending on your symptoms, prior results, radiation concerns, and local expertise.

  • Airway Screening: Tests like Pulmonary Function Tests (PFTs) provide a “functional map” of your breathing [6]. A Chest CT may be used, and a Dynamic Expiratory CT (taking images while forcefully breathing out) is one useful way to see tracheobronchomalacia—where the airway cartilage collapses during exhalation [7][8][9]. However, this involves radiation, so the protocol is tailored to you.
  • Heart and Vessel Screening: RP can affect the aorta (the body’s largest artery) and the heart valves. Baseline screening often includes an Echocardiogram and ECG [10][11]. Because an echocardiogram visualizes the valves but only portions of the proximal aorta, a CT or MRI may be selected when clinically indicated to assess the entire structure [12].

Advanced Tools: Biopsy and PET/CT

  • Cartilage Biopsy: Taking a small sample of cartilage can sometimes provide supportive evidence, but it is not always necessary if your clinical symptoms are clear, and it is not a definitive confirmatory test [5]. Doctors may use it if they need to rule out “mimics” like infection, but the procedure can damage already fragile cartilage.
  • FDG-PET/CT: This scan uses a radioactive sugar tracer to find “hot spots” of inflammation throughout the body. While it can map disease activity, it lacks specificity (it can also reflect infection) and is an adjunct used selectively when it will change management, not a standard test for everyone [13][14].

A Note on Bronchoscopy

A bronchoscopy (using a camera to look inside the lungs) is sometimes needed for a direct look at the airway. However, in suspected RP patients, this procedure carries specific risks, such as triggering an airway spasm or swelling [7]. It should only be performed by specialists—typically a “difficult airway” team—who have a clear rescue plan in place for your breathing during the procedure [15][16].

Common questions in this guide

Is there a single blood test that confirms relapsing polychondritis?
There is no single blood test that definitively confirms relapsing polychondritis. Doctors combine your symptoms, medical history, physical examination, and targeted tests, while checking for other conditions that can look similar.
What do the McAdam, Damiani-Levine, and Michet criteria mean?
These criteria are sets of clinical features doctors use to support classification of relapsing polychondritis. They can miss limited or early disease, so not meeting a checklist does not by itself rule out the condition.
Which tests check whether relapsing polychondritis has affected my airways?
Pulmonary function tests show how well your lungs move air, and chest CT can show changes in the airway. A dynamic expiratory CT, which takes images while you breathe out forcefully, can help detect airway collapse; the choice of imaging depends on your symptoms, prior results, and radiation considerations.
How are the heart and aorta checked in relapsing polychondritis?
An ECG and echocardiogram are often used as baseline heart checks. An echocardiogram can assess the valves and part of the nearby aorta, while CT or MRI may be considered when a more complete view of the aorta is needed.
Are cartilage biopsy and PET/CT always needed for diagnosis?
A cartilage biopsy can sometimes support the diagnosis or help rule out infection, but it is not a definitive test and may injure fragile cartilage. FDG-PET/CT can show areas of inflammation but is not specific, so either test is generally considered selectively.
What safety precautions are important if I need a bronchoscopy?
Bronchoscopy can irritate an already vulnerable airway and may trigger spasm or swelling in someone with suspected relapsing polychondritis. If it is needed, it should be planned by specialists with difficult-airway experience and a clear rescue plan for breathing problems.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do I meet the McAdam or Damiani-Levine classification criteria, or is my case currently considered 'limited' or evolving?
  2. 2.Should my chest CT include both inspiratory and dynamic expiratory views specifically to check for airway collapse (tracheobronchomalacia)?
  3. 3.What is my FVC (forced vital capacity) percentage on my lung function tests, and how does this affect the risk of any future procedures?
  4. 4.Since aortic involvement can be silent, what is the plan for my baseline echocardiogram and follow-up heart screenings?
  5. 5.If we are considering a biopsy or bronchoscopy, what specific 'rescue airway' plan is in place if my breathing is affected during the procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    French practical guidelines for the diagnosis and management of relapsing polychondritis.

    Arnaud L, Costedoat-Chalumeau N, Mathian A, et al.

    La Revue de medecine interne 2023; (44(6)):282-294 doi:10.1016/j.revmed.2023.05.005.

    PMID: 37236870
  2. 2

    Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

    Vitale A, Sota J, Rigante D, et al.

    Current rheumatology reports 2016; (18(1)):3 doi:10.1007/s11926-015-0549-5.

    PMID: 26711694
  3. 3

    Observational study and brief analysis of diagnostic criteria in relapsing polychondritis.

    Rose T, Schneider U, Bertolo M, et al.

    Rheumatology international 2018; (38(11)):2095-2101 doi:10.1007/s00296-018-4121-2.

    PMID: 30084004
  4. 4

    Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort.

    Zhang L, Wu TG, He YJ, et al.

    Clinical rheumatology 2020; (39(7)):2179-2184 doi:10.1007/s10067-019-04852-3.

    PMID: 32036586
  5. 5

    Relapsing polychondritis: A clinical update.

    Longo L, Greco A, Rea A, et al.

    Autoimmunity reviews 2016; (15(6)):539-43.

    PMID: 26876384
  6. 6

    Relapsing polychondritis: tracheobronchial involvement and differential diagnoses.

    Grandière L, Vicaire H, Pop G, et al.

    Journal of thoracic disease 2025; (17(1)):461-475 doi:10.21037/jtd-24-1603.

    PMID: 39975747
  7. 7

    Tracheobronchial involvement of relapsing polychondritis.

    de Montmollin N, Dusser D, Lorut C, et al.

    Autoimmunity reviews 2019; (18(9)):102353 doi:10.1016/j.autrev.2019.102353.

    PMID: 31323366
  8. 8

    Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre.

    Dubey S, Gelder C, Pink G, et al.

    ERJ open research 2021; (7(1)) doi:10.1183/23120541.00170-2020.

    PMID: 33614776
  9. 9

    A Case of Relapsing Polychondritis With Severe Obstructive Ventilatory Defect Caused by a Single Flare-Up.

    Nakagawa R, Kishimoto A, Namiki T, et al.

    Respirology case reports 2025; (13(11)):e70415 doi:10.1002/rcr2.70415.

    PMID: 41262648
  10. 10

    Aortic involvement in relapsing polychondritis: case-based review.

    Erdogan M, Esatoglu SN, Hatemi G, Hamuryudan V

    Rheumatology international 2021; (41(4)):827-837 doi:10.1007/s00296-019-04468-5.

    PMID: 31768631
  11. 11

    Relapsing polychondritis: focus on cardiac involvement.

    Yin R, Zhao M, Xu D, et al.

    Frontiers in immunology 2023; (14()):1218475 doi:10.3389/fimmu.2023.1218475.

    PMID: 37771578
  12. 12

    Aortic involvement in relapsing polychondritis.

    Le Besnerais M, Arnaud L, Boutémy J, et al.

    Joint bone spine 2018; (85(3)):345-351 doi:10.1016/j.jbspin.2017.05.009.

    PMID: 28528280
  13. 13

    Imaging features and clinical value of 18F-FDG PET/CT for predicting airway involvement in patients with relapsing polychondritis.

    Yi JW, Huang JF, Hou P, et al.

    Arthritis research & therapy 2023; (25(1)):198 doi:10.1186/s13075-023-03156-x.

    PMID: 37838717
  14. 14

    Is 18F-FDG PET/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy?

    Zeng Y, Li M, Chen S, et al.

    Arthritis research & therapy 2019; (21(1)):282 doi:10.1186/s13075-019-2083-8.

    PMID: 31831053
  15. 15

    Risk factors associated with severe adverse events in patients with relapsing polychondritis undergoing flexible bronchoscopy.

    Wang ST, Wang J, Gao X, et al.

    Orphanet journal of rare diseases 2024; (19(1)):54 doi:10.1186/s13023-024-03061-9.

    PMID: 38336719
  16. 16

    Respiratory Failure during BIS-Guided Sedation in a Patient with Relapsing Polychondritis: A Case Report.

    Lee J, Moon H, Hong S, et al.

    Medicina (Kaunas, Lithuania) 2022; (59(1)) doi:10.3390/medicina59010065.

    PMID: 36676688

This page is for informational purposes only and does not constitute medical advice. Your specialist should choose and interpret relapsing polychondritis tests based on your symptoms, prior results, radiation concerns, and procedure risks.

Get notified when new evidence is published on Relapsing polychondritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.